Jürgen Engel
Geen lopende functies
Profiel
Dr. Jürgen Engel is President & Chief Executive Officer at AEterna Zentaris, Inc. He is on the Board of Directors at Isotechnika Pharma, Inc.
Dr. Engel was previously employed as Chief Executive Officer by Zentaris GmbH.
He received his undergraduate degree from the University of Regensburg and a doctorate degree from the Technical University of Braunschweig.
Eerdere bekende functies van Jürgen Engel
Bedrijven | Functie | Einde |
---|---|---|
AETERNA ZENTARIS INC. | President | 15-04-2013 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Director/Board Member | 18-02-2011 |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Chief Executive Officer | - |
Zentaris GmbH | President | - |
Opleiding van Jürgen Engel
University of Regensburg | Undergraduate Degree |
Technische Universität Braunschweig | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AETERNA ZENTARIS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Zentaris GmbH | |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Commercial Services |